Common Sense for Drug Policy - Link to home page

Wednesday, February 08, 2023
Search using CSDP's own search tool or use

WWW Common Sense

Home page

About CSDP

PSA Campaign

Check out these other CSDP news pages:
Anti-Drug Media Campaign
Asia and the US Drug War
Bush's Cabinet
Chronic Pain Management
Communities Against the Drug War
Conferences & Events
DARE Admits Failure
Drug Control Alternatives
Families Targeted by Drug War
Federal Drug Control Strategy
Hemp News
Heroin & Heroin Addiction Treatment
Higher Education Act (HEA) Reform
International Reform
Mandatory Minimums
Medical Marijuana
Narco-Funded Terrorism
New Mexico
New York
Pain Management
Police Shootings & Botched Raids
Prop 36
Racial Profiling
Recommended Reading
Research News
South America
Treatment Alternatives to Incarceration
United Kingdom Moves Toward Reform
United Nations: News and Reports

Drug War Facts

Research Archive

Coalition for Medical Marijuana

Managing Chronic Pain

Drug War Distortions

Safety First

Get Active!

Drug Truth Network


Drug Strategy

Drugs and Terror

Recommended Reading

Site Map

link to 
Drug War Facts - page opens in new window
in the Family

Online Drug Library

Research Resources

Contact Common Sense

Back to Methamphetamine page

Federal Meth Act Would Overrule State Law

Des Moines Register, June 8, 2005

By Lee Rood, Register Staff Writer

Momentum is building in Congress to pass a nationwide law restricting the sale of pseudoephedrine, the popular decongestant used to make the highly addictive drug methamphetamine.

However, state leaders are upset that recent changes to the Combat Meth Act would allow the federal government to supersede tougher legislation enacted this year in Iowa to better control sales of meth's main ingredient. Narcotics officials in Iowa and elsewhere say they fear drug companies - which spend more money to lobby Congress than any other industry - are persuading key sponsors to water down the federal act, usurping strides made by states in recent months to curb meth production.

Much of the concern nationally has centered on Iowa, where lawmakers this spring passed the toughest law in the country on restricting pseudoephedrine sales. State legislators, faced with a second-in-the-nation meth-lab problem, decided to require pseudoephedrine products to be sold in pharmacies, except for the lowest-dose liquids.

A new draft of the federal measure would allow retail outlets to continue selling liquid- and starch-based pediatric medicines that can be used to make meth - and require all states to follow suit.

Iowa donations

A review of , a Web site associated with the nonpartisan Center for Responsive Politics that tracks political contributions, shows candidates for Congress from Iowa in 2004 received at least $333,171 from sources noted as "pharmaceuticals/health products." The top recipient was Sen. Charles Grassley, a Republican who received $260,421 from such sources, the Web site reports.

"Our legislation ought to be the national model," Iowa Gov. Tom Vilsack said Tuesday, upon hearing of the changes. "Anything less than what Iowa is doing can minimize the security that can come from this bill."

As originally drafted, the Combat Meth Act, which was co-sponsored by U.S. Sens. Chuck Grassley and Tom Harkin of Iowa, would not have superseded state laws that were more restrictive than the federal measure.

However, the proposal has since been modified by its original authors, U.S. Sens. Dianne Feinstein, a Democrat from California, and Jim Talent, a Republican from Missouri, Iowa officials said.

Scott Gerber, a spokesman for Feinstein, said his office had been "working with the industry and Republicans to try to get a bill that everyone can support. . . . The pharmaceutical industry would fight strongly anything that wasn't a national standard."

Vilsack, Grassley and Harkin - as well as Iowa's drug czar and attorney general - have said they do not support the recent changes.

"I am concerned," said Marvin Van Haaften, who heads the Governor's Office of Drug Control Policy. "We spent over two years debating, studying, discussing and wisely constructing the (state) bill that would become our final product. Now, the federal measure is in a state of flux, and we could easily wind up with a bill that is considerably weaker than ours."

Iowa's state law, as well as local ordinances and voluntary restrictions taken by retailers in recent months, already are being credited for a steep drop in meth-lab production. The number of clandestine labs discovered statewide dropped 44 percent from January to April 2005 compared with the same period in 2004.

The statewide attention focused on pseudoephedrine "has triggered intense paranoia and fear among meth-makers," Van Haaften said.

Even greater reductions are expected in coming months, as Iowa's law, which went into effect May 21, and those recently enacted in surrounding states take hold.

Narcotics officials, meanwhile, say they have reason to fear the national bill could ultimately undermine states' efforts to get meth labs under control: Drug companies and their trade organizations have successfully fought tougher pseudoephedrine restrictions for years in many hard-hit meth states.

According to the Center for Public Integrity, an independent watchdog group based in Washington, D.C., drug companies and their trade organizations spent $758.8 million from 1998 to 2004 to lobby members of Congress.

The Consumer Healthcare Products Association, perhaps the most vocal opponent of pseudoephedrine restrictions, dramatically increased spending last year to almost $430,000, up from $260,000 in 2003, according to the association.

A representative of the Consumer Healthcare Products Association did not return phone calls Tuesday seeking comment.

Lonnie Wright, who heads Oklahoma's narcotics bureau, said he opposes any national law that would supersede state anti-meth laws, even though the national measure was originally drafted to mirror Oklahoma's current restrictions.

"The state of Oklahoma does not want to be told it can't solve its own crime problems, and I'm sure neither does Iowa," Wright said.

A congressional hearing to discuss changes to the Combat Meth Act has been scheduled for June 28 in Washington.

Allison Dobson, a spokeswoman for Harkin's office, said the bill is in the "very early stages" of being debated.

"We are doing all we can to address these concerns," she said. "The goal is to have the federal law modeled on Iowa's."

Save This Page to

Home Drug War Facts Public Service
Managing Chronic Pain
Get Active About Common Sense Addict In
The Family
Effective Drug
Control Strategy
Drug War Distortions Recommended

copyright © 2000-2007, Common Sense for Drug Policy
Kevin B. Zeese, President -- Mike Gray, Chairman -- Robert E. Field, Co-Chairman -- Melvin R. Allen, Board Member -- Doug McVay, Director of Research & Editor
1377-C Spencer Ave., Lancaster, PA 17603
tel 717-299-0600 - fax 717-393-4953
Updated: Wednesday, July 13, 2005   ~   Accessed: 11332 times
Email us